NO892269L - Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene. - Google Patents

Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.

Info

Publication number
NO892269L
NO892269L NO89892269A NO892269A NO892269L NO 892269 L NO892269 L NO 892269L NO 89892269 A NO89892269 A NO 89892269A NO 892269 A NO892269 A NO 892269A NO 892269 L NO892269 L NO 892269L
Authority
NO
Norway
Prior art keywords
proteins
hypergylycosyled
hepatity
cassette
expression
Prior art date
Application number
NO89892269A
Other languages
English (en)
Other versions
NO892269D0 (no
Inventor
Peter J Kniskern
William J Miller
Ronald W Ellis
Arpi Hagopian
Shigeko Yamazaki
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO892269D0 publication Critical patent/NO892269D0/no
Publication of NO892269L publication Critical patent/NO892269L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO89892269A 1988-06-03 1989-06-02 Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene. NO892269L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20276488A 1988-06-03 1988-06-03

Publications (2)

Publication Number Publication Date
NO892269D0 NO892269D0 (no) 1989-06-02
NO892269L true NO892269L (no) 1989-12-04

Family

ID=22751163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89892269A NO892269L (no) 1988-06-03 1989-06-02 Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.

Country Status (11)

Country Link
EP (1) EP0344864A3 (no)
JP (1) JPH02150292A (no)
KR (1) KR900000091A (no)
AU (1) AU616976B2 (no)
DK (1) DK272189A (no)
FI (1) FI892683L (no)
IL (1) IL90408A0 (no)
NO (1) NO892269L (no)
NZ (1) NZ229260A (no)
PT (1) PT90690A (no)
ZA (1) ZA894182B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341074C (en) 1987-06-22 2000-08-08 Hans A. Thoma Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
CA2022108A1 (en) * 1989-07-31 1991-02-01 Cheryl A. Schulman Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
JP3026029B2 (ja) * 1991-04-26 2000-03-27 財団法人阪大微生物病研究会 組換え水痘ウイルスとその作製法
IL101651A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Hepatitis b virus surface proteins with reduced host carbohydrate content
IL101653A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Multiple hepatitis b virus surface proteins which form particles
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
DE4301932A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hefewirtsstämme mit Defekten in der N-Glycosylierung
DE4301904A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hypoglycosylierte recombinante Glucoseoxidase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69202A (en) * 1982-09-08 1991-08-16 Smith Kline Rit Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
JPS61158798A (ja) * 1984-12-28 1986-07-18 Japan Found Cancer Res Ｂ型肝炎ウイルス表面抗原の製造法
WO1988006185A1 (en) * 1987-02-11 1988-08-25 Scripps Clinic And Research Foundation Retroviral expression vectors and methods for producing hbv antigens
WO1988010301A1 (en) * 1987-06-22 1988-12-29 Mccormick And Jones Engineering Ltd. Hepatitis b surface antigen vaccine

Also Published As

Publication number Publication date
NZ229260A (en) 1994-02-25
JPH02150292A (ja) 1990-06-08
EP0344864A2 (en) 1989-12-06
DK272189D0 (da) 1989-06-02
PT90690A (pt) 1989-12-29
KR900000091A (ko) 1990-01-30
AU616976B2 (en) 1991-11-14
IL90408A0 (en) 1990-01-18
EP0344864A3 (en) 1990-09-12
ZA894182B (en) 1990-02-28
DK272189A (da) 1989-12-04
FI892683A0 (fi) 1989-06-01
NO892269D0 (no) 1989-06-02
FI892683A7 (fi) 1989-12-04
AU3597089A (en) 1989-12-07
FI892683L (fi) 1989-12-04

Similar Documents

Publication Publication Date Title
NO882075D0 (no) 9-alfa-hydroksysteroider, deres fremstilling, en fremgangsmaate for fremstilling av de tilsvarende 9(11)-dehydro-derivater samt farmasoeytiske preparater inneholdend
IT8819179A0 (it) Dispositivo di emodiafiltrazione erelativo procedimento di emodiafiltrazione.
DK299087D0 (da) Proteins and derivatives thereof
NO890062D0 (no) 3,5-dihydrokarboksylsyrer og derivater derav samt fremgangsmaater for fremstilling av disse.
NO892269D0 (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
DK84489D0 (da) Praeparater
NO895031L (no) 2-imino-6-polyfluoralkoksybenzotiazol samt fremstilling derav.
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
NO893794D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
NO894185D0 (no) Fremgangsmaate for fremstilling av 1-buten- og/eller heksener.
DK469189A (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NO891985L (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
DK131188A (da) 3-(2-halogenalkyl)-1,4-oxathiiner og 2(2-halogenalkyl)-1,4-dithiiner, samt farmaceutiske praeparater indeholdende disse til behandling af leukaemi og tumorer
DK354989D0 (da) Modificerede proteiner
NO891926D0 (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
DK32689D0 (da) Teicoplaninhydrazider samt fremstilling og anvendelse deraf
NO893796D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
DK511687D0 (da) Farmaceutisk praeparat, samt fremstilling og anvendelse heraf
NO893795L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO912279L (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
DK63089D0 (da) 1-aminomethyl-3-(2,4-diflour-3-chlorphenyl)-4-cyanopyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK396089D0 (da) 6-aroyl-substituerede 3,4-dihydro-2h-benzopyraner samt fremstilling og anvendelse deraf
NO873478D0 (no) Fremgangsmaate for helbredelse av benskade samt preparat dertil.